bluebird bio, Inc.
BCMA CHIMERIC ANTIGEN RECEPTORS
Last updated:
Abstract:
The invention provides improved compositions for adoptive T cell therapies for B cell related conditions.
Status:
Application
Type:
Utility
Filling date:
23 Oct 2020
Issue date:
11 Feb 2021